Literature DB >> 11871490

Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.

G Tillotson1, X Zhao, K Drlica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11871490     DOI： 10.1016/S1473-3099(01)00090-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.

Authors:  H-G Wetzstein
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.

Authors:  George P Allen; Glenn W Kaatz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.